Genedx Holdings Corp (WGS)

$50.15 +1.94 (4.02%)
Market Cap 1.43B
Revenue (ttm) 427.54M
Net Income (ttm) -21.02M
EPS (ttm) N/A
PE Ratio 58.16
Forward PE N/A
Profit Margin -4.92%
Debt to Equity Ratio 0.38
Volume 1,304,800
Avg Vol 1,293,516
Day's Range N/A - N/A
Shares Out 29.69M
Stochastic %K 86%
Beta 2.06
Analysts Strong Sell
Price Target $77.00

Company Profile

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 888 729 1206
Fax: 201 421 2010
Address:
North Tower, 6th Floor 333 Ludlow Street, Stamford, United States
PencilNeckGeek
PencilNeckGeek May. 28 at 7:06 PM
$WGS Sold my shares I bought at $37. Don't want to be too greedy
0 · Reply
LucienW
LucienW May. 28 at 2:30 PM
$TEM $WGS $GRAL any news for the move today?
1 · Reply
Macarran
Macarran May. 28 at 2:18 PM
$WGS https://www.globenewswire.com/news-release/2026/05/20/3298600/35219/en/Barrack-Rodos-Bacine-Investigates-GeneDx-Holdings-Corp-NASDAQ-WGS-For-Possible-Securities-Fraud.html
0 · Reply
logartmq
logartmq May. 28 at 1:50 PM
$PLAB reminded me of $WGS dropped like they were going bankrupt and rebound in the next couple of days
1 · Reply
11thestate
11thestate May. 26 at 2:17 PM
$SMFR now $WGS — Sema4 Holdings Agreed to Settle With Investors Sema4 Holdings has agreed to settle with investors regarding it overstated the capabilities of Centrellis and the business benefits expected from the GeneDx transaction. The agreement has already been submitted to the court for final approval. The settlement aims to compensate affected shareholders. If you purchased $SMFR between January 18, 2022 and August 15, 2022 , you may be eligible to file a claim and recover part of your losses. You can review the details and submit your claim here https://11th.com/cases/sema4-investor-suit
0 · Reply
Jasooon
Jasooon May. 24 at 3:07 AM
$WGS
1 · Reply
Jasooon
Jasooon May. 23 at 2:46 PM
$WGS
0 · Reply
Unicorn2020
Unicorn2020 May. 22 at 3:14 PM
$WGS Sold $49.20 bought back $45.70. Let's go. Love to trade this baby for over $10K profit in every two days.
0 · Reply
Buckanator
Buckanator May. 22 at 3:02 PM
$WGS Let’s see 44 so I can add
0 · Reply
v92
v92 May. 22 at 2:21 PM
$WGS 👀
0 · Reply
Latest News on WGS
GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative- HBSS

May 28, 2026, 9:00 AM EDT - 1 day ago

GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative- HBSS

WGS

GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

May 26, 2026, 4:05 PM EDT - 2 days ago

GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

WGS

Barrack, Rodos & Bacine Investigates GeneDx Holdings Corp. (NASDAQ: WGS) For Possible Securities Fraud

May 20, 2026, 9:30 AM EDT - 9 days ago

Barrack, Rodos & Bacine Investigates GeneDx Holdings Corp. (NASDAQ: WGS) For Possible Securities Fraud

WGS

GeneDx Holdings Corp. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

May 5, 2026, 8:09 AM EDT - 24 days ago

GeneDx Holdings Corp. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

WGS

GeneDx Holdings Earnings Call Transcript: Q1 2026

May 4, 2026, 4:30 PM EDT - 24 days ago

GeneDx Holdings Earnings Call Transcript: Q1 2026

GeneDx Holdings Slides: Q1 2026

May 4, 2026, 4:30 PM EDT - 24 days ago

GeneDx Holdings Slides: Q1 2026

GeneDx Holdings Earnings release: Q1 2026

May 4, 2026, 4:30 PM EDT - 24 days ago

GeneDx Holdings Earnings release: Q1 2026

GeneDx Holdings Quarterly report: Q1 2026

May 4, 2026, 4:30 PM EDT - 24 days ago

GeneDx Holdings Quarterly report: Q1 2026

GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook

May 4, 2026, 4:05 PM EDT - 24 days ago

GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook

WGS

GeneDx Holdings Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 weeks ago

GeneDx Holdings Proxy statement: Proxy filing

GeneDx Holdings Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 weeks ago

GeneDx Holdings Proxy statement: Proxy filing

GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026

Apr 13, 2026, 4:05 PM EDT - 6 weeks ago

GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026

WGS

Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing

Mar 11, 2026, 5:00 PM EDT - 2 months ago

Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing

WGS

GeneDx Holdings Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 11, 2026, 3:00 PM EDT - 2 months ago

GeneDx Holdings Transcript: Barclays 28th Annual Global Healthcare Conference

GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C

Mar 10, 2026, 8:30 AM EDT - 2 months ago

GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C

WGS

GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership

Mar 9, 2026, 8:30 AM EDT - 2 months ago

GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership

WGS

HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Feb 25, 2026, 8:03 PM EST - 3 months ago

HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

WGS

GeneDx to Participate in Upcoming Investor Conferences

Feb 25, 2026, 8:30 AM EST - 3 months ago

GeneDx to Participate in Upcoming Investor Conferences

WGS

GeneDx Holdings Earnings Call Transcript: Q4 2025

Feb 23, 2026, 8:30 AM EST - 3 months ago

GeneDx Holdings Earnings Call Transcript: Q4 2025

GeneDx Holdings Annual report: Q4 2025

Feb 23, 2026, 8:30 AM EST - 3 months ago

GeneDx Holdings Annual report: Q4 2025

GeneDx Holdings Earnings release: Q4 2025

Feb 23, 2026, 8:30 AM EST - 3 months ago

GeneDx Holdings Earnings release: Q4 2025

GeneDx Holdings Slides: Q4 2025

Feb 23, 2026, 8:30 AM EST - 3 months ago

GeneDx Holdings Slides: Q4 2025

INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

Feb 23, 2026, 8:07 AM EST - 3 months ago

INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

WGS

GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

Feb 23, 2026, 6:30 AM EST - 3 months ago

GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

WGS

TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World's Most Influential Leaders in Health

Feb 11, 2026, 9:05 AM EST - 3 months ago

TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World's Most Influential Leaders in Health

WGS

GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026

Feb 3, 2026, 8:00 AM EST - 4 months ago

GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026

WGS

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

Jan 15, 2026, 11:24 AM EST - 4 months ago

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

WGS

GeneDx Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:00 PM EST - 4 months ago

GeneDx Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference

GeneDx Holdings Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:00 PM EST - 4 months ago

GeneDx Holdings Slides: 44th Annual J.P. Morgan Healthcare Conference

Why is GeneDx stock crashing on Monday?

Jan 12, 2026, 3:03 PM EST - 4 months ago

Why is GeneDx stock crashing on Monday?

WGS

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

Jan 12, 2026, 7:30 AM EST - 4 months ago

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

WGS

GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset

Jan 8, 2026, 8:30 AM EST - 5 months ago

GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset

WGS

GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care

Jan 7, 2026, 8:30 AM EST - 5 months ago

GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care

WGS

GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care

Jan 6, 2026, 8:30 AM EST - 5 months ago

GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care

WGS

GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025

Jan 5, 2026, 8:30 AM EST - 5 months ago

GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025

WGS

GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference

Dec 30, 2025, 8:00 AM EST - 5 months ago

GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference

WGS

JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year

Dec 15, 2025, 8:30 AM EST - 5 months ago

JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year

WGS

Eight stock picks to play one of the healthiest corners of the market

Dec 11, 2025, 10:37 AM EST - 6 months ago

Eight stock picks to play one of the healthiest corners of the market

ALNY ASND INSM MASI NTRA PODD UNH

GeneDx Holdings Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 3, 2025, 1:30 PM EST - 6 months ago

GeneDx Holdings Transcript: Piper Sandler 37th Annual Healthcare Conference

GeneDx Holdings Transcript: Jefferies London Healthcare Conference 2025

Nov 19, 2025, 6:00 AM EST - 6 months ago

GeneDx Holdings Transcript: Jefferies London Healthcare Conference 2025

GeneDx Holdings Transcript: Stifel 2025 Healthcare Conference

Nov 12, 2025, 2:00 PM EST - 7 months ago

GeneDx Holdings Transcript: Stifel 2025 Healthcare Conference

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

Nov 6, 2025, 8:00 AM EST - 7 months ago

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

WGS

GeneDx Holdings Earnings Call Transcript: Q3 2025

Oct 28, 2025, 8:30 AM EDT - 7 months ago

GeneDx Holdings Earnings Call Transcript: Q3 2025

GeneDx Holdings Quarterly report: Q3 2025

Oct 28, 2025, 8:30 AM EDT - 7 months ago

GeneDx Holdings Quarterly report: Q3 2025

GeneDx Holdings Earnings release: Q3 2025

Oct 28, 2025, 8:30 AM EDT - 7 months ago

GeneDx Holdings Earnings release: Q3 2025

GeneDx Holdings Slides: Q3 2025

Oct 28, 2025, 8:30 AM EDT - 7 months ago

GeneDx Holdings Slides: Q3 2025

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

Oct 28, 2025, 6:30 AM EDT - 7 months ago

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

WGS

GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims

Oct 27, 2025, 8:00 AM EDT - 7 months ago

GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims

WGS

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

Oct 22, 2025, 8:00 AM EDT - 7 months ago

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

WGS

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

Oct 20, 2025, 8:00 AM EDT - 7 months ago

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

WGS

GeneDX CEO Katherine Stueland on how the company is using AI to save lives

Oct 15, 2025, 3:30 PM EDT - 8 months ago

GeneDX CEO Katherine Stueland on how the company is using AI to save lives

WGS

GeneDX CEO Katherine Stueland on if the cuts at NIH impact the company

Oct 15, 2025, 11:45 AM EDT - 8 months ago

GeneDX CEO Katherine Stueland on if the cuts at NIH impact the company

WGS

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

Oct 15, 2025, 9:15 AM EDT - 8 months ago

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

ILMN WGS

How GeneDX CEO Katherine Stueland is using AI to save lives

Oct 14, 2025, 3:17 PM EDT - 8 months ago

How GeneDX CEO Katherine Stueland is using AI to save lives

WGS

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

Oct 14, 2025, 8:00 AM EDT - 8 months ago

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

WGS

GeneDx to Partner with Florida's Sunshine Genetics Network, Launching Nation's First State-Backed Genomic Newborn Screening Program

Oct 13, 2025, 8:00 AM EDT - 8 months ago

GeneDx to Partner with Florida's Sunshine Genetics Network, Launching Nation's First State-Backed Genomic Newborn Screening Program

WGS

PencilNeckGeek
PencilNeckGeek May. 28 at 7:06 PM
$WGS Sold my shares I bought at $37. Don't want to be too greedy
0 · Reply
LucienW
LucienW May. 28 at 2:30 PM
$TEM $WGS $GRAL any news for the move today?
1 · Reply
Macarran
Macarran May. 28 at 2:18 PM
$WGS https://www.globenewswire.com/news-release/2026/05/20/3298600/35219/en/Barrack-Rodos-Bacine-Investigates-GeneDx-Holdings-Corp-NASDAQ-WGS-For-Possible-Securities-Fraud.html
0 · Reply
logartmq
logartmq May. 28 at 1:50 PM
$PLAB reminded me of $WGS dropped like they were going bankrupt and rebound in the next couple of days
1 · Reply
11thestate
11thestate May. 26 at 2:17 PM
$SMFR now $WGS — Sema4 Holdings Agreed to Settle With Investors Sema4 Holdings has agreed to settle with investors regarding it overstated the capabilities of Centrellis and the business benefits expected from the GeneDx transaction. The agreement has already been submitted to the court for final approval. The settlement aims to compensate affected shareholders. If you purchased $SMFR between January 18, 2022 and August 15, 2022 , you may be eligible to file a claim and recover part of your losses. You can review the details and submit your claim here https://11th.com/cases/sema4-investor-suit
0 · Reply
Jasooon
Jasooon May. 24 at 3:07 AM
$WGS
1 · Reply
Jasooon
Jasooon May. 23 at 2:46 PM
$WGS
0 · Reply
Unicorn2020
Unicorn2020 May. 22 at 3:14 PM
$WGS Sold $49.20 bought back $45.70. Let's go. Love to trade this baby for over $10K profit in every two days.
0 · Reply
Buckanator
Buckanator May. 22 at 3:02 PM
$WGS Let’s see 44 so I can add
0 · Reply
v92
v92 May. 22 at 2:21 PM
$WGS 👀
0 · Reply
Buckanator
Buckanator May. 22 at 1:37 PM
$WGS Holding long term from $33.50,
0 · Reply
Macarran
Macarran May. 22 at 1:21 PM
$WGS https://www.globenewswire.com/news-release/2026/05/20/3298600/35219/en/Barrack-Rodos-Bacine-Investigates-GeneDx-Holdings-Corp-NASDAQ-WGS-For-Possible-Securities-Fraud.html
1 · Reply
PhishTourFunds
PhishTourFunds May. 22 at 1:12 AM
$WGS Anyone catch that falling knife? This post was prime for finding entries.
1 · Reply
Jasooon
Jasooon May. 21 at 11:19 PM
$WGS https://casdincapital.com/
0 · Reply
Jasooon
Jasooon May. 21 at 11:03 PM
$WGS
0 · Reply
Unicorn2020
Unicorn2020 May. 21 at 4:20 PM
$WGS Took profit @ $49. 20. Will wait and see before buying back cheaper.
0 · Reply
PencilNeckGeek
PencilNeckGeek May. 21 at 3:15 PM
$WGS Well, glad I loaded on the dip
0 · Reply
Unicorn2020
Unicorn2020 May. 21 at 10:38 AM
$WGS Whoa, insiders just bought 2 million shares average at $40.
1 · Reply
Energy2024
Energy2024 May. 21 at 10:02 AM
$WGS
0 · Reply
Joseph_Ballin
Joseph_Ballin May. 20 at 11:58 PM
$WGS https://www.sec.gov/Archives/edgar/data/1534260/000091957426003627/xslF345X06/ownership.xml
0 · Reply
Unicorn2020
Unicorn2020 May. 20 at 8:00 PM
$WGS $50 is coming. Likely tomorrow. Yassss.
0 · Reply
quiet_investor_
quiet_investor_ May. 19 at 4:38 PM
$WGS if this goes below my average cost, I am buyer.
0 · Reply